Bevacizumab Suppression of Establishment of Micrometastases in Experimental Ocular Melanoma | Zendy

Hua Yang | Zendy; Martine J. Jager | Zendy; Hans E. Grossniklaus | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Bevacizumab Suppression of Establishment of Micrometastases in Experimental Ocular Melanoma

Author(s) -

Hua Yang,

Martine J. Jager,

Hans E. Grossniklaus

Publication year - 2010

Publication title -

investigative ophthalmology and visual science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.935

H-Index - 218

eISSN - 1552-5783

pISSN - 0146-0404

DOI - 10.1167/iovs.09-4755

Subject(s) - bevacizumab , melanoma , medicine , angiogenesis , in vitro , vasculogenic mimicry , in vivo , vascular endothelial growth factor , cancer research , pathology , ocular melanoma , immunohistochemistry , cell culture , micrometastasis , metastasis , cancer , chemotherapy , biology , vegf receptors , biochemistry , genetics , microbiology and biotechnology

This study was undertaken to determine whether anti-vascular endothelial growth factor (VEGF) therapy inhibits growth of primary uveal melanoma and spread of its hepatic micrometastases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research